Literature DB >> 12853535

Cardiopulmonary effects of lipid emulsions in patients with ARDS.

Marion Faucher1, Fabienne Bregeon, Marc Gainnier, Xavier Thirion, Jean-Pierre Auffray, Laurent Papazian.   

Abstract

STUDY
OBJECTIVES: Lipid emulsions have been suspected of inducing certain modifications in gas exchange and pulmonary hemodynamics. The aim of this prospective study was to evaluate the hemodynamic and pulmonary effects of two lipid emulsions.
DESIGN: Prospective, randomized, double-blind, crossover study.
SETTING: Medical and surgical ICU in a French university hospital. PATIENTS: Eighteen patients presenting ARDS.
INTERVENTIONS: Each patient received a 6-h infusion of a 20% fat emulsion containing 100% long-chain triglycerides (LCTs) and a 6-h infusion of 50% LCTs/50% medium-chain triglycerides (MCTs) 20% lipid emulsion at the rate of 1.0 mL/kg/h. An 18-h period with no lipids separated the two periods. An additional 18-h period after the end of the second lipid emulsion administration was observed prior to the final measurements. MEASUREMENTS AND
RESULTS: The MCT/LCT emulsion increased the PaO(2)/fraction of inspired oxygen (FIO(2)) ratio (p = 0.005) compared with LCT emulsion alone. The mean (+/- SD) PaO(2)/FIO(2) ratio increased from 165 +/- 55 to 191 +/- 64 mm Hg after 1 h of LCT/MCT administration (p < 0.03), and to 175 +/- 46 mm Hg after 6 h. Moreover, there was an increase in oxygen delivery after 6 h of LCT/MCT administration (p < 0.001 vs baseline). While a time-related increase in mean pulmonary artery pressure (p = 0.012) during lipid administration was found, no effect of the kind of lipid emulsion was observed. The time-related increase in cardiac index (p = 0.002) was more marked when the patients received the LCT/MCT emulsion (p = 0.002). Pulmonary vascular resistances were not affected by the kind of lipid emulsion.
CONCLUSIONS: The present work showed that while the LCT emulsion induced no deleterious effects on oxygenation in ARDS patients, the LCT/MCT emulsion improved the PaO(2)/FIO(2) ratio and had a further beneficial effect on oxygen delivery.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853535     DOI: 10.1378/chest.124.1.285

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Intravenous fat emulsion: a potential novel antidote.

Authors:  Danielle E Turner-Lawrence; William Kerns Ii
Journal:  J Med Toxicol       Date:  2008-06

Review 2.  [Nutrition and immunonutrition in septic patients].

Authors:  K Mayer; M Schaefer; H Walmrath; F Grimminger; W Seeger
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

3.  Effects of an omega-3 fatty acid-enriched lipid emulsion on eicosanoid synthesis in acute respiratory distress syndrome (ARDS): A prospective, randomized, double-blind, parallel group study.

Authors:  Joan Sabater; Joan Ramon Masclans; Judit Sacanell; Pilar Chacon; Pilar Sabin; Mercè Planas
Journal:  Nutr Metab (Lond)       Date:  2011-04-08       Impact factor: 4.169

4.  Efficacy and safety of parenteral omega 3 fatty acids in ventilated patients with acute lung injury.

Authors:  Ajay Gupta; Deepak Govil; Shaleen Bhatnagar; Sachin Gupta; Jyoti Goyal; Sweta Patel; Himanshu Baweja
Journal:  Indian J Crit Care Med       Date:  2011-04

Review 5.  The possible role of intravenous lipid emulsion in the treatment of chemical warfare agent poisoning.

Authors:  Arik Eisenkraft; Avshalom Falk
Journal:  Toxicol Rep       Date:  2016-01-18

6.  Effects on hemodynamics and gas exchange of omega-3 fatty acid-enriched lipid emulsion in acute respiratory distress syndrome (ARDS): a prospective, randomized, double-blind, parallel group study.

Authors:  Joan Sabater; Joan Ramon Masclans; Judit Sacanell; Pilar Chacon; Pilar Sabin; Merce Planas
Journal:  Lipids Health Dis       Date:  2008-10-23       Impact factor: 3.876

Review 7.  The Role of Omega-3 Polyunsaturated Fatty Acids in the Treatment of Patients with Acute Respiratory Distress Syndrome: A Clinical Review.

Authors:  M García de Acilu; S Leal; B Caralt; O Roca; J Sabater; J R Masclans
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.